Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Tests in bacteria, cells, and mice all came back negative, suggesting the compound does not pose carcinogenic risk through DNA damage mechanisms
Catalog Preview Online Ordering Coming Soon The cart is temporarily disabled while BGX Performance prepares secure payment processing
The peptide exhibits high-affinity copper binding (Kd ~10 M), creating a stable complex that delivers copper to cells while protecting against copper-induced oxidative damage
KLOW Peptide Blend Clinical Evidence Context No direct evidence: No published human or animal trial has evaluated the four-peptide KLOW combination
US$ 25.45
US$ 27.44
US$ 28.11
